Table 2.

Relationship between miR-140 and miR-196a Expression with Clinicopathological Parameters of BC Patients. (n = 110). BC, Breast cancer

Clinical pathological criteria			miR–140 Expression			miR–196a Expression
			Low 53 (%)	High 57 (%)	P-value	Low 49 (%)	High 61 (%)	P-value
Age	<50	75	32	43	NS	29	46	NS
	>50	35	21	14		20	15
histological grade	I	21	9	12	NS	8	13	0.038
	II	79	38	41		35	44
	III	10	6	4		6	4
Progesterone receptor	negative	34	20	14	NS	18	16	NS
	positive	76	33	43		31	45
Estrogen receptors	negative	27	12	15	NS	9	18	NS
	positive	83	41	42		40	43
HER2	negative	99	50	49	NS	45	54	NS
	positive	11	3	8		4	7
lymph node metastasis	negative	46	21	25	0.023	18	28	0.012
	positive	64	32	32		31	33
Stage	I	16	7	9	0.009	7	9	0.001
	II	72	37	35		35	37
	III	18	8	10		7	11
	IV	4	1	3		0	4
Tumor size	<20mm	39	16	23	NS	14	25	NS
	20-49mm	61	32	29		31	30
	>50mm	10	5	5		4	6